NYSE:MMS - MAXIMUS Stock Price, Forecast & News

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

MAXIMUS announced a quarterly dividend on Wednesday, January 8th. Stockholders of record on Friday, February 14th will be paid a dividend of $0.28 per share on Friday, February 28th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date of this dividend is Thursday, February 13th. View MAXIMUS's Dividend History.

MAXIMUS declared that its Board of Directors has initiated a share buyback plan on Monday, June 25th 2018, which permits the company to repurchase $200,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 4.9% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

MAXIMUS, Inc. (NYSE:MMS) issued its quarterly earnings results on Tuesday, November, 19th. The health services provider reported $0.93 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.94 by $0.01. The health services provider earned $754.97 million during the quarter, compared to analysts' expectations of $756.40 million. MAXIMUS had a net margin of 8.34% and a return on equity of 21.09%. The business's revenue was up 35.2% on a year-over-year basis. During the same quarter last year, the business posted $0.71 earnings per share. View MAXIMUS's Earnings History.

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for MAXIMUS.

MAXIMUS updated its FY 2020 Pre-Market earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of $$3.95-4.15 for the period, compared to the Thomson Reuters consensus estimate of $$4.07. The company issued revenue guidance of $$3.15-3.3 billion, compared to the consensus revenue estimate of $$3.17 billion.

2 brokerages have issued twelve-month target prices for MAXIMUS's stock. Their forecasts range from $77.00 to $81.00. On average, they anticipate MAXIMUS's stock price to reach $79.00 in the next twelve months. This suggests a possible upside of 5.6% from the stock's current price. View Analyst Price Targets for MAXIMUS.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

News articles about MMS stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. MAXIMUS earned a coverage optimism score of 1.6 on InfoTrie's scale. They also assigned press coverage about the health services provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for MAXIMUS.

MAXIMUS saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 1,670,000 shares, an increase of 6.4% from the December 15th total of 1,570,000 shares. Based on an average daily trading volume, of 393,600 shares, the short-interest ratio is currently 4.2 days. Approximately 2.6% of the shares of the company are short sold. View MAXIMUS's Current Options Chain.

Some companies that are related to MAXIMUS include Visa (V), Mastercard (MA), Fidelity National Information Servcs (FIS), Fiserv (FISV), Automatic Data Processing (ADP), Global Payments (GPN), Worldpay (WP), Paychex (PAYX), FleetCor Technologies (FLT), Total System Services (TSS), Broadridge Financial Solutions (BR), Jack Henry & Associates (JKHY), The Western Union (WU), WEX (WEX) and Euronet Worldwide (EEFT).

Based on aggregate information from My MarketBeat watchlists, some companies that other MAXIMUS investors own include Altria Group (MO), Tesla (TSLA), Bank of America (BAC), Southwest Airlines (LUV), Wells Fargo & Co (WFC), Gilead Sciences (GILD), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Dominion Energy (D) and New Oriental Education & Tech Grp (EDU).

MAXIMUS's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (0.73%), West Coast Financial LLC (0.16%), Assenagon Asset Management S.A. (0.08%), Nisa Investment Advisors LLC (0.06%), Louisiana State Employees Retirement System (0.02%) and Bowling Portfolio Management LLC (0.02%). Company insiders that own MAXIMUS stock include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Institutional Ownership Trends for MAXIMUS.

MMS stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Bowling Portfolio Management LLC, Nisa Investment Advisors LLC, State of Alaska Department of Revenue, West Coast Financial LLC and Verus Financial Partners Inc.. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Insider Buying and Selling for MAXIMUS.

MMS stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Zeke Capital Advisors LLC, Private Trust Co. NA, First National Bank of Omaha, Larson Financial Group LLC, Camelot Portfolios LLC, Zurcher Kantonalbank Zurich Cantonalbank and Louisiana State Employees Retirement System. View Insider Buying and Selling for MAXIMUS.

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MMS stock can currently be purchased for approximately $74.79.

MAXIMUS has a market capitalization of $4.79 billion and generates $2.89 billion in revenue each year. The health services provider earns $240.82 million in net income (profit) each year or $3.72 on an earnings per share basis. MAXIMUS employs 29,600 workers across the globe.View Additional Information About MAXIMUS.

The official website for MAXIMUS is http://www.maximus.com/.

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]